ArticleEuropean journal of clinical pharmacology2021

Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.

Gustavo H Oliveira-Paula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.